ERFURT and BERLIN, Germany and
TORONTO, Aug. 11, 2020 /CNW/ - AMP German Cannabis Group
Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) and
Eve & Co. Incorporated ("Eve & Co.") (TSXV: EVE) (QTCQX:
EEVVF) announce they have entered into a supply agreement for the
purchase and export to Germany of
European Union Good Manufacturing Practice (EU-GMP) medical
cannabis flower. The first large import to Germany from Canada is expected before the end of 2020 with
50 to 100 kilograms and monthly imports of up to 100 kilograms to
begin 2021.
Eve & Co. greenhouse cultivation facility is located in
Strathroy, Ontario, Canada and
received EU 'Certificate of GMP Compliance of a Manufacturer' ("EU
GMP") from the Government of Upper Bavaria in Germany on March 6,
2020.
Dr. Stefan Feuerstein, Director
and President of AMP, commented: "AMP has signed a supply purchase
agreement with Canadian cannabis licence holder, Eve & Co. We
are qualifying additional Canadian suppliers under the Covid-19
travel restrictions to prepare for higher demand from German
patients in 2021 as doctors and pharmacists become more informed
about the medical benefits of cannabis."
Dr. Feuerstein added, "AMP's Roundtable Series, which is
available at amp-eu.de/roundtable, discusses medical cannabis
developments and issues in Germany. In our first episode,
AMP's Roundtable Series guest, Dr. Franjo Grotenhermen, a German
medical doctor and a medical cannabis expert with a high reputation
in Europe, joins me and moderator,
Mr. Holger Scholze in an in-depth
discussion about the current situation in Germany."
Ms. Melinda Rombouts, President
and CEO of Eve & Co., commented: "We are among a small number
of Canadian cannabis licence holders able to export to Germany and the EU. We are committed to
servicing the European market with cannabis for medical purposes
and have been ramping up our cultivation capacity in our
greenhouse. Our agreement with AMP is another milestone in being a
cannabis supplier for the EU, and we are looking forward to a
fruitful collaboration."
About Eve & Co. Incorporated
Eve & Co.,
through its wholly-owned subsidiary, Natural MedCo Ltd., holds
cultivation and processing licences under the Cannabis Act
(Canada) for the production and
sale of various cannabis products, including dried cannabis,
cannabis plants and extraction of cannabis oil and has received EU
GMP certification. Natural MedCo Ltd. was Canada's first female-founded licensed
producer of medicinal marijuana and received its cultivation
licence from Health Canada in 2016. Eve & Co. is led by a team
of agricultural experts and has a licensed 1,000,000 square foot
greenhouse located in Strathroy,
Ontario.
For more information, please visit: www.evecannabis.ca
About AMP German Cannabis Group Inc.
AMP German
Cannabis Group is licensed to import European Union - Good
Manufacturing Practice (EU-GMP) medical cannabis and sell to
pharmaceutical distributors or pharmacists directly, the only
point-of-sale for medical cannabis to German patients.
AMP has entered into a non-exclusive distribution agreement for
medical cannabis with a leading distributor of pharmaceuticals
products to more than 13,000 pharmacies throughout Germany for
monthly shipments starting in the second half of 2020.
For more information, please visit: www.amp-eu.com
AMP social media links:
- Twitter: www.twitter.com/AMP_Cannabis
- LinkedIn: www.linkedin.com/company/ampgermancannabisgroup
- Facebook: www.facebook.com/AMPGCG/
- Instagram: www.instagram.com/ampgcg/
AMP Media Kit: www.amp-eu.com/media-kit
Eve & Co social media links:
- Instagram: https://www.instagram.com/evecannabis/
- Twitter: https://twitter.com/EveCoCannabis
- LinkedIn:
https://www.linkedin.com/company/eve-co-incorporated/
- Facebook: www.facebook.com/EveCoInc/
Neither the CSE and TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
CSE) accepts responsibility for the adequacy or accuracy of this
release.
This news release contains forward-looking statements that
are based on the expectations, estimates and projections
regarding its business and the economic environments in which AMP
and Eve & Co (the "Companies") operate, including with
respect to their ability to execute on export sales and the timing
thereof. Although the Companies believe the expectations expressed
in such forward-looking statements are based on reasonable
assumptions, such statements are not guarantees of future
performance and involve risks and uncertainties that are difficult
to control or predict. Therefore, actual outcomes and results may
differ materially from those expressed in these forward-looking
statements and readers should not place undue reliance on such
statements. These forward-looking statements speak only as of the
date on which they are made, and the Companies undertake no
obligation to update them publicly to reflect new information or
the occurrence of future events or circumstances unless otherwise
required to do so by law.
SOURCE AMP German Cannabis Group Inc.